Adaptive clinical trials are becoming very popular because of their flexibility in allowing mid-stream changes of sample size, endpoints, populations, etc. At the same time, they have been regarded with mistrust because they can produce bizarre results in very extreme settings. Understanding the advantages and disadvantages of these rapidly developing methods is a must. This paper reviews flexi...

This article extends previous research on the recovery of weak factor loadings in confirmatory factor analysis (CFA) by exploring the effects of adding the mean structure. This issue has not been examined in previous research. This study is based on the framework of Yung and Bentler (1999) and aims to examine the conditions that affect the recovery of weak factor loadings when the model include...

BACKGROUND Statistical methods that use the mid-p approach are useful tools to analyze categorical data, particularly for small and moderate sample sizes. Mid-p tests strike a balance between overly conservative exact methods and asymptotic methods that frequently violate the nominal level. Here, we examine a mid-p version of the McNemar exact conditional test for the analysis of paired binomia...

We prove the following conjecture of Narayana: there are no nontrivial dominance refinements of the Smirnov two-sample test if and only if the two sample sizes are relatively prime. We also count the number of natural significance levels of the Smirnov two-sample test in terms of the sample sizes and relate this to the Narayana conjecture. In particular, Smirnov tests with relatively prime samp...

This article examines effects of sample size and other design features on correspondence between factors obtained from analysis of sample data and those present in the population from which the samples were drawn. We extend earlier work on this question by examining these phenomena in the situation in which the common factor model does not hold exactly in the population. We present a theoretica...

Monte Carlo simulations are increasingly used to predict pharmacokinetic variability of antimicrobials in a population. We investigated the sample size necessary to provide robust pharmacokinetic predictions. To obtain reasonably robust predictions, a nonparametric model derived from a sample population size of >/=50 appears to be necessary as the input information.

BACKGROUND Researchers commonly employ strategies to increase participation in health studies. These include use of incentives and intensive reminders. There is, however, little evidence regarding the quantitative effect that such strategies have on study results. We present an analysis of data from a case-control study of Campylobacter enteritis in England to assess the usefulness of a two-rem...

The main purpose of this paper is to introduce and study the behavior of minimum ϕ -divergence estimators as an alternative to the maximum-likelihood estimator in latent class models for binary items. As it will become clear below, minimum ϕ -divergence estimators are a natural extension of the maximum-likelihood estimator. The asymptotic properties of minimum ϕ -divergence estimators for laten...

In clinical study, calculation for sample size is often done using the frequentist framework. However, several methods of calculation using the Bayesian framework have been proposed. In this paper, we propose a method for the determination of sample sizes using the index θ = P ( π1 > π2|X1, X2 ) , where X1 and X2 denote the binomial random variables for trials n1 and n2 and parameters π1 and π2...